Don’t fret the normal discipline with rebalancing – Callan

As the end of the year approaches, the issue of rebalancing for pension funds – a vexed one in the market volatility of the past year – is becoming more acute. US-based adviser Callan Associates is advising clients to depart from the normal disciplines around rebalancing in these extreme conditions.

In a new research note, Callan has listed several steps for investors facing rebalancing and transition needs in the current environment.

The consulting firm notes that this may represent a departure from traditional consulting advice to adhere to disciplined rebalancing no matter what the markets are doing.
The research note advises:

The full research note is available at: www.callan.com

Sponsored Content

Leave a Comment

Sort content by

Sovereigns versus citizens

As sovereign wealth funds continue to grow, some are running into tussles with citizens over particular investments or the purpose of the fund. Transparency and greater engagement can help.

Return targets head downward

The challenging market environment is putting pressure on pension funds. In response, many are lowering return targets, rather than taking on more risk or requesting larger contributions.

Never underestimate quality

USS's COO Howard Brindle is one of the most experienced investment operations executives in the pension industry, he talks about business transformation and the importance of talent.

Board make-up matters

The more political appointees and worker representatives sit on US pension fund boards, the more those funds will respond to incentives that encourage riskier investing, research has found.

McKinsey: Long game is best play

Calls for a long-term investment focus have lacked a sophisticated metric to back them up – until now. The McKinsey Global Institute has found tangible benefits from shunning short-termism.

On the geopolitical horizon

It’s impossible for asset owners to predict the year’s geopolitical upsets. Diversification will be the key to a resilient portfolio.

Previous